| 摘要 |
FIELD: medicine. ^ SUBSTANCE: method involves applying peptide containing amino acid sequence of Thr-R1-Lue-Ile-Asp-Asn-Asn-Ala-Thr-Glu-Glu-Ile-Leu-Tyr, where R1 is the D-alanine (SEQ ID N:2) for treating patients for neurodegenerative disorder or myelinogenesis disorder by introducing effective dose of this peptide. Given disorders for which the medicament has proved to be useful are polyneuropathy, mononeuropathy, neuroma, nerve compression, nerve injury, contusion, tumor or incomplete spinal cord transection, infarction or injury of brain stem cells, thalamus or cerebral cortex, compression, rupture or inflammation of dorsal ganglia roots, postpoliosyndrome, traumatic or ischemic injury of central or peripheral nervous system, disseminated sclerosis. ^ EFFECT: enhanced effectiveness of treatment. ^ 6 cl, 3 dwg, 6 tbl |
